Infectious bronchitis coronavirus inhibits STAT1 signaling and requires accessory proteins for resistance to type I interferon activity

Journal of Virology

Volumn 89, Issue 23, 2015, Pages 12047-12057

  Kint, Joeri ^a,b   Dickhout, Annemiek ^a   Kutter, Jasmin ^a   Maier, Helena J ^c   Britton, Paul ^c   Koumans, Joseph ^b   Pijlman, Gorben P ^a   Fros, Jelke J ^a   Wiegertjes, Geert F ^a   Forlenza, Maria ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b INTERVET INTERNATIONAL BV   (Netherlands)

^c INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; STAT1 PROTEIN; UNCLASSIFIED DRUG; VIRAL ACCESSORY PROTEIN 3A; VIRAL ACCESSORY PROTEIN 3B; VIRAL ACCESSORY PROTEIN 5A; VIRAL ACCESSORY PROTEIN 5B; VIRUS PROTEIN; LUCIFERASE; PRIMER DNA; VIRAL PROTEIN;

ANIMAL CELL; ANTIVIRAL RESISTANCE; ARTICLE; AVIAN INFECTIOUS BRONCHITIS VIRUS; CONTROLLED STUDY; CYTOKINE RESPONSE; EMBRYO; GENE; GENE ACTIVATION; GENE TRANSLOCATION; INNATE IMMUNITY; INTERFERON STIMULATED GENE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VIRAL CLEARANCE; ANALYSIS OF VARIANCE; ANIMAL; CELL CULTURE; CHICK EMBRYO; CHLOROCEBUS AETHIOPS; GENETICS; HEK293 CELL LINE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; VERO CELL LINE; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CHICK EMBRYO; DNA PRIMERS; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INFECTIOUS BRONCHITIS VIRUS; INTERFERON TYPE I; LUCIFERASES; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; VERO CELLS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 84949651326     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01057-15     Document Type: Article

References (52)

1. Gorbalenya AE, Enjuanes L, Ziebuhr J, Snijder EJ. 2006. Nidovirales: evolving the largest RNA virus genome. Virus Res 117:17-37. http://dx.doi.org/10.1016/j.virusres.2006.01.017.
2. Cavanagh D. 2007. Coronavirus avian infectious bronchitis virus. Vet Res 38:281-297. http://dx.doi.org/10.1051/vetres:2006055.
3. Britton P, Cavanagh D. 2007. Avian coronavirus diseases and infectious bronchitis vaccine development, p 161-181. In Thiel V (ed), Coronaviruses: molecular and cellular biology. Caister Academic Press, Norfolk, United Kingdom.
4. Kint J, Fernandez-Gutierrez M, Maier HJ, Britton P, Langereis MA, Koumans J, Wiegertjes GF, Forlenza M. 2015. Activation of the chicken type I interferon response by infectious bronchitis coronavirus. J Virol 89:1156-1167. http://dx.doi.org/10.1128/JVI.02671-14.
5. Rose KM, Elliott R, Martinez-Sobrido L, Garcia-Sastre A, Weiss SR. 2010. Murine coronavirus delays expression of a subset of interferonstimulated genes. J Virol 84:5656-5669. http://dx.doi.org/10.1128/JVI.00211-10.
6. Zhou H, Zhao J, Perlman S. 2010. Autocrine interferon priming in macrophages but not dendritic cells results in enhanced cytokine and chemokine production after coronavirus infection. mBio 1:e00219-10. http://dx.doi.org/10.1128/mBio.00219-10.
7. Devaraj SG, Wang N, Chen Z, Tseng M, Barretto N, Lin R, Peters CJ, Tseng CT, Baker SC, Li K. 2007. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J Biol Chem 282:32208-32221. http://dx.doi.org/10.1074/jbc. M704870200.
8. Menachery VD, Eisfeld AJ, Schafer A, Josset L, Sims AC, Proll S, Fan S, Li C, Neumann G, Tilton SC, Chang J, Gralinski LE, Long C, Green R, Williams CM, Weiss J, Matzke MM, Webb-Robertson BJ, Schepmoes AA, Shukla AK, Metz TO, Smith RD, Waters KM, Katze MG, Kawaoka Y, Baric RS. 2014. Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses. mBio 5:e01174-14. http://dx.doi.org/10.1128/mBio.01174-14.
9. Roth-Cross JK, Martinez-Sobrido L, Scott EP, Garcia-Sastre A, Weiss SR. 2007. Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levels. J Virol 81:7189-7199. http://dx.doi.org/10.1128/JVI.00013-07.
10. Dedeurwaerder A, Olyslaegers DA, Desmarets LM, Roukaerts ID, Theuns S, Nauwynck HJ. 4 November 2013. The ORF7-encoded accessory protein 7a of feline infectious peritonitis virus as a counteragent against interferon-alpha induced antiviral response. J Gen Virol http://dx.doi.org/10.1099/vir.0.058743-0.
11. Hart BJ, Dyall J, Postnikova E, Zhou H, Kindrachuk J, Johnson RF, Olinger GG, Frieman MB, Holbrook MR, Jahrling PB, Hensley L. 9 December 2013. Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. J Gen Virol http://dx.doi.org/10.1099/vir.0.061911-0.
12. Matthews KL, Coleman CM, van der Meer Y, Snijder EJ, Frieman MB. 17 January 2014. The ORF4b-encoded accessory proteins of MERScoronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signaling. J Gen Virol http://dx.doi.org/10.1099/vir.0.062059-0.
13. Pei J, Sekellick MJ, Marcus PI, Choi IS, Collisson EW. 2001. Chicken interferon type I inhibits infectious bronchitis virus replication and associated respiratory illness. J Interferon Cytokine Res 21:1071-1077. http://dx.doi.org/10.1089/107999001317205204.
14. Otsuki K, Maeda J, Yamamoto H, Tsubokura M. 1979. Studies on avian infectious bronchitis virus (IBV). III. Interferon induction by and sensitivity to interferon of IBV. Arch Virol 60:249-255.
15. Yang Y, Zhang L, Geng H, Deng Y, Huang B, Guo Y, Zhao Z, Tan W. 2013. The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell 4:951-961. http://dx.doi.org/10.1007/s13238-013-3096-8.
16. Niemeyer D, Zillinger T, Muth D, Zielecki F, Horvath G, Suliman T, Barchet W, Weber F, Drosten C, Muller MA. 2013. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J Virol 87:12489-12495. http://dx.doi.org/10.1128/JVI.01845-13.
17. Cruz J, Sola I, Becares M, Alberca B, Plana J, Enjuanes L, Zuniga S. 2011. Coronavirus gene 7 counteracts host defenses and modulates virus virulence. PLoS Pathog 7:e1002090. http://dx.doi.org/10.1371/journal.ppat.1002090.
18. Koetzner CA, Kuo L, Goebel SJ, Dean AB, Parker MM, Masters PS. 2010. Accessory protein 5a is a major antagonist of the antiviral action of interferon against murine coronavirus. J Virol 84:8262-8274. http://dx.doi.org/10.1128/JVI.00385-10.
19. Kopecky-Bromberg SA, Martínez-Sobrido L, Frieman M, Baric RA, Palese P. 2007. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol 81:548-557. http://dx.doi.org/10.1128/JVI.01782-06.
20. Zhao L, Jha BK, Wu A, Elliott R, Ziebuhr J, Gorbalenya AE, Silverman RH, Weiss SR. 2012. Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host Microbe 11:607-616. http://dx.doi.org/10.1016/j.chom.2012.04.011.
21. Narayanan K, Huang C, Makino S. 2008. Coronavirus accessory proteins, p 235-244. In Perlman S, Gallagher T, Snijder E (ed), Nidoviruses. ASM Press, Washington, DC. http://dx.doi.org/10.1128/9781555815790.ch15.
22. Hodgson T, Britton P, Cavanagh D. 2006. Neither the RNA nor the proteins of open reading frames 3a and 3b of the coronavirus infectious bronchitis virus are essential for replication. J Virol 80:296-305. http://dx.doi.org/10.1128/JVI.80.1.296-305.2006.
23. Casais R, Davies M, Cavanagh D, Britton P. 2005. Gene 5 of the avian coronavirus infectious bronchitis virus is not essential for replication. J Virol 79:8065-8078. http://dx.doi.org/10.1128/JVI.79.13.8065-8078.2005.
24. Casais R, Thiel V, Siddell SG, Cavanagh D, Britton P. 2001. Reverse genetics system for the avian coronavirus infectious bronchitis virus. J Virol 75:12359-12369. http://dx.doi.org/10.1128/JVI.75.24.12359-12369.2001.
25. Kint J, Maier HJ, Jagt E. 2015. Quantification of infectious bronchitis coronavirus by titration in vitro and in ovo. Methods Mol Biol 1282:89-98.http://dx.doi.org/10.1007/978-1-4939-2438-7_9.
26. Schultz U, Rinderle C, Sekellick MJ, Marcus PI, Staeheli P. 1995. Recombinant chicken interferon from Escherichia coli and transfected COS cells is biologically active. Eur J Biochem 229:73-76. http://dx.doi.org/10.1111/j.1432-1033.1995.0073l.x.
27. Paulson M, Press C, Smith E, Tanese N, Levy DE. 2002. IFN-stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff. Nat Cell Biol 4:140-147. http://dx.doi.org/10.1038/ncb747.
28. Frieman M, Yount B, Heise M, Kopecky-Bromberg SA, Palese P, Baric RS. 2007. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J Virol 81:9812-9824. http://dx.doi.org/10.1128/JVI.01012-07.
29. de Wilde AH, Raj VS, Oudshoorn D, Bestebroer TM, van Nieuwkoop S, Limpens RW, Posthuma CC, van der Meer Y, Barcena M, Haagmans BL, Snijder EJ, van den Hoogen BG. 2013. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment. J Gen Virol 94:1749-1760. http://dx.doi.org/10.1099/vir.0.052910-0.
30. Dent S. 2014. Proteomic analysis of IBV Infection to study the effect of the accessory proteins 5a and 5b. Ph. D. thesis. University of Reading, Reading, United Kingdom.
31. Kindler E, Jonsdottir HR, Muth D, Hamming OJ, Hartmann R, Rodriguez R, Geffers R, Fouchier RA, Drosten C, Muller MA, Dijkman R, Thiel V. 2013. Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. mBio 4:e00611-12. http://dx.doi.org/10.1128/mBio.00611-12.
32. Kamitani W, Huang C, Narayanan K, Lokugamage KG, Makino S. 2009. A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein. Nat Struct Mol Biol 16:1134-1140. http://dx.doi.org/10.1038/nsmb.1680.
33. Huang C, Lokugamage KG, Rozovics JM, Narayanan K, Semler BL, Makino S. 2011. Alphacoronavirus transmissible gastroenteritis virus nsp1 protein suppresses protein translation in mammalian cells and in cell-free HeLa cell extracts but not in rabbit reticulocyte lysate. J Virol 85:638-643. http://dx.doi.org/10.1128/JVI.01806-10.
34. Züst R, Cervantes-Barragan L, Kuri T, Blakqori G, Weber F, Ludewig B, Thiel V. 2007. Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines. PLoS Pathog 3:e109. http://dx.doi.org/10.1371/journal.ppat.0030109.
35. Vervelde L, Matthijs MG, van Haarlem DA, de Wit JJ, Jansen CA. 2013. Rapid NK-cell activation in chicken after infection with infectious bronchitis virus M41. Vet Immunol Immunopathol 151:337-341. http://dx.doi.org/10.1016/j.vetimm.2012.11.012.
36. Zhou H, Perlman S. 2006. Preferential infection of mature dendritic cells by mouse hepatitis virus strain JHM. J Virol 80:2506-2514. http://dx.doi.org/10.1128/JVI.80.5.2506-2514.2006.
37. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. 2003. Treatment of SARS with human interferons. Lancet 362:293-294. http://dx.doi.org/10.1016/S0140-6736(03)13973-6.
38. Zheng B, He ML, Wong KL, Lum CT, Poon LL, Peng Y, Guan Y, Lin MC, Kung HF. 2004. Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma). J Interferon Cytokine Res 24:388-390. http://dx.doi.org/10.1089/1079990041535610.
39. Yoshikawa T, Hill TE, Yoshikawa N, Popov VL, Galindo CL, Garner HR, Peters CJ, Tseng CT. 2010. Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndromeassociated coronavirus infection. PLoS One 5:e8729. http://dx.doi.org/10.1371/journal.pone.0008729.
40. Wathelet MG, Orr M, Frieman MB, Baric RS. 2007. Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. J Virol 81:11620-11633. http://dx.doi.org/10.1128/JVI.00702-07.
41. Cruz JL, Becares M, Sola I, Oliveros JC, Enjuanes L, Zuniga S. 2013. Alphacoronavirus protein 7 modulates host innate immune response. J Virol 87:9754-9767. http://dx.doi.org/10.1128/JVI.01032-13.
42. Kindler E, Thiel V. 2014. To sense or not to sense viral RNA: essentials of coronavirus innate immune evasion. Curr Opin Microbiol 20:69-75. http://dx.doi.org/10.1016/j.mib.2014.05.005.
43. Zhang R, Jha BK, Ogden KM, Dong B, Zhao L, Elliott R, Patton JT, Silverman RH, Weiss SR. 2013. Homologous 2', 5'-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity. Proc Natl Acad Sci U S A http://dx.doi.org/10.1073/pnas.1306917110.
44. Davies MT. 2009. Subcellular location and protein interactions of the infectious bronchitis virus gene 3 and 5 accessory proteins. Ph. D. thesis. University of Warwick, Coventry, United Kingdom.
45. Knoops K, Kikkert M, Worm SH, Zevenhoven-Dobbe JC, van der Meer Y, Koster AJ, Mommaas AM, Snijder EJ. 2008. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol 6:e226. http://dx.doi.org/10.1371/journal.pbio.0060226.
46. Ulasli M, Verheije MH, de Haan CA, Reggiori F. 2010. Qualitative and quantitative ultrastructural analysis of the membrane rearrangements induced by coronavirus. Cell Microbiol 12:844-861. http://dx.doi.org/10.1111/j.1462-5822.2010.01437.x.
47. Maier HJ, Hawes PC, Cottam EM, Mantell J, Verkade P, Monaghan P, Wileman T, Britton P. 2013. Infectious bronchitis virus generates spherules from zippered endoplasmic reticulum membranes. mBio 4:e00801-13.http://dx.doi.org/10.1128/mBio.00801-13.
48. Lundin A, Dijkman R, Bergström T, Kann N, Adamiak B, Hannoun C, Kindler E, Jónsdóttir HR, Muth D, Kint J, Forlenza M, Müller MA, Drosten C, Thiel V, Trybala E. 2014. Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the Middle East respiratory syndrome virus. PLoS Pathog 10: e1004166. http://dx.doi.org/10.1371/journal.ppat.1004166.
49. van Hemert MJ, van den Worm SH, Knoops K, Mommaas AM, Gorbalenya AE, Snijder EJ. 2008. SARS-coronavirus replication/transcription complexes are membrane-protected and need a host factor for activity in vitro. PLoS Pathog 4:e1000054. http://dx.doi.org/10.1371/journal.ppat.1000054.
50. Neuman BW, Angelini MM, Buchmeier MJ. 2014. Does form meet function in the coronavirus replicative organelle? Trends Microbiol http://dx.doi.org/10.1016/j.tim.2014.06.003.
51. Versteeg GA, Bredenbeek PJ, van den Worm SH, Spaan WJ. 2007. Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition. Virology 361:18-26. http://dx.doi.org/10.1016/j.virol.2007.01.020.
52. Zhou H, Perlman S. 2007. Mouse hepatitis virus does not induce beta interferon synthesis and does not inhibit its induction by doublestranded RNA. J Virol 81:568-574. http://dx.doi.org/10.1128/JVI.01512-06.